Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AA Colony stimulating factors
L03AA09 Sargramostim
D05803 Sargramostim (USP/INN) <US>
USP drug classification [BR:br08302]
Immunological Agents
Immunostimulants
Colony-stimulating Factors
Sargramostim
D05803 Sargramostim (USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
22 Respiratory organ agents
229 Miscellaneous
2290 Miscellaneous
D05803 Sargramostim (USP/INN); Sargramostim (genetical recombination) (JAN)
Drug groups [BR:br08330]
Immunological agent
DG01753 Colony stimulating factor
DG01782 Granulocyte macrophage colony-stimulating factors (GM-CSF)
D05803 Sargramostim
Drug classes [BR:br08332]
Immunological agent
DG01753 Colony stimulating factor
D05803 Sargramostim
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
CSF and other factor receptors
CSF2RA (GMCSFR, CD116)
D05803 Sargramostim (USP/INN) <JP/US>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D05803
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D05803
